Target animal safety and tolerance study of pyrantel pamoate paste (19.13% w/w pyrantel base) administered orally to horses.
Abstract: Pyrantel pamoate paste (19.13% w/w pyrantel base) for the treatment of tapeworm, Anoplocephala spp was evaluated for target animal safety and tolerance in horses treated orally at 0, 1, 3, 5, and 10 times the clinical dose of 13.2 mg pyrantel base/kg body weight administered daily for six consecutive days. Parameters evaluated included clinical signs, food and water consumption, body weights, physical examinations, clinical pathology (hematology, coagulation, serum chemistry, urinalyses, and fecal examinations), complete necropsy, organ weights, and histopathology. No adverse events or test article-related effects were observed in any treatment group during daily clinical observations of the test animals. Statistically significant changes (P < .05) lacked a dose- and/or time-dependent trend and were considered incidental. Administration of pyrantel pamoate paste did not produce any macroscopic or microscopic tissue effects in any dose group of either sex. The no-observed-effect-level (NOEL) for pyrantel pamoate paste, when administered orally to horses once daily for 6 consecutive days, was determined to be 132 mg/kg/day. Pyrantel pamoate paste (19.13% w/w pyrantel base) can be safely administered orally to horses at 13.2 mg of pyrantel base/kg for the treatment of Anoplocephala infestations.
Publication Date: 2006-03-22 PubMed ID: 16550493
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Randomized Controlled Trial
- Research Support
- Non-U.S. Gov't
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research examines the safety and effectiveness of a medication known as pyrantel pamoate paste for the treatment of tapeworm infections in horses. It specifically investigates the drug’s impact on the animals’ health and physiology when delivered at various dosage levels.
Objective and Methodology
- The goal of this research was to assess both the safety and tolerance of pyrantel pamoate paste (19.13% w/w pyrantel base), specifically towards Anoplocephala spp, a common species of tapeworm in horses. The assessment involved delivering the medication orally at different doses (0, 1, 3, 5, and 10 times the clinical dose), on a daily basis, for six consecutive days.
- A variety of health indicators were monitored throughout the study. These included clinical symptoms, food and water consumption rates, body weight, physical examinations records, and an array of clinical pathology tests such as blood work, coagulation assessments, serum chemistry, urine and stool tests.
- The researchers also conducted complete necropsies, organ weight measuremnts, and histopathological examinations to explore any possible tissue effects of the drug administration.
Findings and Conclusion
- The research found no adverse effects or significant changes linked to the administration of the pyrantel pamoate paste in any treatment group during the daily clinical assessments of the horses. This was indicated by statistically significant changes that exhibited no consistent dose- or time-dependent pattern, leading to their classification as incidental, or coincidental.
- Analysis of macroscopic and microscopic tissue didn’t show any deleterious effects of the drug at any dose in either sex of horses.
- The study determined the no-observed-effect-level (NOEL) for pyrantel pamoate paste, when delivered orally to horses once daily for six consecutive days, to be 132 mg/kg/day.
- The results of this research suggest that pyrantel pamoate paste (19.13% w/w pyrantel base) can be safely administered orally to horses at a dose of 13.2 mg of pyrantel base/kg for the treatment of Anoplocephala infestations without causing severe health issues or significant side effects.
Cite This Article
APA
Marchiondo AA, TerHune TN, Herrick RL.
(2006).
Target animal safety and tolerance study of pyrantel pamoate paste (19.13% w/w pyrantel base) administered orally to horses.
Vet Ther, 6(4), 311-324.
Publication
Researcher Affiliations
- IVX Animal Health (formerly Phoenix Scientific), 3915 S 48th Street Terrace, St Joseph, MO, 64503, USA.
MeSH Terms
- Administration, Oral
- Animal Welfare
- Animals
- Antinematodal Agents / administration & dosage
- Antinematodal Agents / therapeutic use
- Antinematodal Agents / toxicity
- Cestoda / drug effects
- Cestode Infections / drug therapy
- Cestode Infections / veterinary
- Dose-Response Relationship, Drug
- Female
- Horse Diseases / drug therapy
- Horses
- Male
- No-Observed-Adverse-Effect Level
- Pyrantel Pamoate / administration & dosage
- Pyrantel Pamoate / therapeutic use
- Pyrantel Pamoate / toxicity
- Safety
- Time Factors
- Treatment Outcome
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists